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Introduction
Mycobacterium bovis is the causative agent of
bovine tuberculosis, a disease responsible for
annual losses to global agriculture of $3 billion and
with serious repercussions for public health and
animal welfare. The UK program for the control of
bovine tuberculosis involves regular testing of cat-
tle with a crude preparation of mycobacterial anti-
gens (tuberculin), followed by compulsory slaugh-
ter of positive reactors. However, in the last decade
the number of herd breakdowns has been increasing
across the UK, especially in the south-west, where
prevalence has now risen to 3.5% of cattle herds.
This has worrying implications for the control strat-
egy, which currently costs ∼£25 million/year.
A range of techniques exist for the genetic typ-
ing of M. bovis isolates. These include restriction
fragment length polymorphism (RFLP) with probes
such as the polymorphic glycine-rich sequences
(PGRS), a minisatellite method (VNTR), and
spacer-oligonucleotide typing (spoligotyping). The
application of these techniques has allowed the
integration of molecular and epidemiological data
to aid in disease control. The current method of
choice for isolates at the Veterinary Laboratories
Agency (VLA) is spoligotyping, a rapid simple
method based on a polymorphic region called the
direct repeat (DR) locus [1]. This locus is com-
posed of multiple 36bp DR copies that are inter-
spersed by non-repetitive, unique short sequences
called spacers. Isolates of M. bovis differ in the
presence or absence of spacers and adjacent DRs,
allowing a barcode to be generated for each molec-
ular type (Figure 1).
At the VLA approximately 16000 strains have
been spoligotyped. Analysis of this data shows that
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Figure 1. Spoligotype patterns of dominant GB M. bovis molecular types. The spacer pattern at the DR locus is shown as
blocks () to indicate the presence of a spacer, while empty lanes show the absence of a spacer. The strain numbers in the
extreme left-hand column follow the VLA numbering convention. Spacers 39–43 are not shown
in the UK there are only 10 major spoligotypes.
Furthermore, two of these spoligotypes, 09 and
17, represent over 65% of all isolates. Type 09
is dispersed throughout the world, while Type 17
appears unique to Great Britain (GB), suggesting
recent clonal expansion. Indeed, the majority of GB
isolates can be related back to the Type 09, simply
on the basis of spoligotype pattern (Figure 1). This
suggests that DR deletions are clonal, and that
progenitor clones would be predicted to have more
spacers.
Prior to the availability of the M. bovis genome
sequence, comparative genomics of the M. tubercu-
losis complex was performed using hybridization-
based methods with micro- and macroarrays.
These experiments revealed 10 deletions from the
genome of M. bovis, ranging in size from ∼1t o
12.7 kb [3,6]. The deletions impacted on a range of
metabolic functions and putative virulence factors,
e.g. loss of the RD5 locus removed the genes for
three phospholipase C enzymes from the genome, a
known virulence factor in Listeria and Clostridium
spp. [7]. However, a fourth phospholipase gene,
plcD, is intact in M. bovis and may compensate
for the loss of the other genes. The RD7 locus
encompasses one of the mce operons, originally
described by Riley and colleagues as a putative
mycobacterial invasin [2]. The genome sequence
revealed that there are in fact four mce operons
in M. tuberculosis, encoding a family of 24 pro-
teins [5]. It is therefore possible that loss of one
mce operon may be compensated by the remain-
ing loci.
Analysis of the presence or absence of these
deletions across the M. tuberculosis complex all-
owed a phylogenetic tree to be generated show-
ing the evolutionary relationships between the
strains [4]. From this analysis it was clear that the
genome of M. bovis had undergone the greatest
number of deletions, and that gene loss had been a
major force in shaping the genome. However, the
role these deletions played in the evolution of the
bacillus is unclear. While they may represent host-
adaptive mutations, it is also possible that they rep-
resent the ﬁxation of deleterious mutations, or the
removal of genetic redundancy. It is also unclear
whether this process of deletion is continuing in
‘modern’ M. bovis.
Results
The aim of this project is to determine whether
clones of M. bovis, clustered on the basis of molec-
ular type, share phenotypic characteristics that may
explain their relative success as pathogens.
DNA microarray technology allows the large-
scale analysis of whole genomes for comparative
genomics. Using this technology we can there-
fore rapidly screen the genomes of M. bovis strains
for deletions, using an M. tuberculosis H37Rv
array and exploiting the >99.9% sequence identity
between the two bacilli. This study will concen-
trate on the 10 most prevalent GB spoligotypes, i.e.
Types 09,17,12,11,13,22,25,35,20 and 10. Our ini-
tial analysis has focused on the variation between
the two dominant types, 09 and 17. Previously we
had used a range of lipid proﬁling techniques to
identify an alteration in the cell wall lipid proﬁles
between these strains. However, due to the fact
that ∼10% of the coding capacity of the genome is
dedicated to lipid metabolism, it was not possible
to determine the genetic basis for this phenotype.
The array-based approach has, however, identiﬁed
 Crown Copyright 2002 Comp Funct Genom 2002; 3: 342–344.344 J. Inwald et al.
a deletion of a cluster of genes involved in lipid
metabolism from M. bovis type 17. Deletion of this
locus may therefore be responsible for the altered
lipid proﬁle of this strain, and we are actively purs-
ing this possibility.
A second approach that we are taking is to
determine whether deleted genes are immuno-
genic. Our analysis suggests that some of the
deletions that we have identiﬁed are linked to
spoligotype, in that every member of the same
spoligotype shows the same deletion. Therefore,
if any of the proteins encoded on these deletions
encoded immunogenic epitopes, we may be able
to use this as a basis for immunotyping. Our ini-
tial work focused on one gene deleted from Type
17. We used overlapping peptides to represent
the encoded protein, and then screened these pep-
tides in pools against whole blood from M. bovis-
infected animals. Interferon-gamma (IFN-γ) con-
centration was determined using the BOVIGAM
ELISA kit (Biocore AH, Omaha, NE). One pool
of peptides from this protein was recognized by
the majority of Type 09 M. bovis infected ani-
mals, offering the possibility of developing a
rapid immunotyping method that would circum-
vent the need for culture of M. bovis from infected
animals.
Conclusions
Microarray-based comparative genomics allows
genomes to be rapidly scanned for deletion events.
This is a powerful method when it is linked
to molecular epidemiological data, allowing the
identiﬁcation of genetic polymorphisms that could
help explain phenotypic traits. This knowledge will
help in our understanding of the mechanisms of
genome variation and ultimately the evolution of
the bacillus.
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